Cover Image
市場調查報告書

全球腎臟用醫療設備及服務市場:各產品,應用領域,地區 - 成長,趨勢,預測(2018年∼2023年)

Global Renal Medical Devices and Services Market - Segmented by Product, Application, and Geography - Growth, Trends, and Forecast (2018 - 2023)

出版商 Mordor Intelligence LLP 商品編碼 391362
出版日期 內容資訊 英文 116 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
全球腎臟用醫療設備及服務市場:各產品,應用領域,地區 - 成長,趨勢,預測(2018年∼2023年) Global Renal Medical Devices and Services Market - Segmented by Product, Application, and Geography - Growth, Trends, and Forecast (2018 - 2023)
出版日期: 2018年04月01日 內容資訊: 英文 116 Pages
簡介

全球腎臟用醫療設備及服務市場,從2018年到2023年以約6%的年複合成長率發展的事預計。各地區中,北美成為最大的市場,其次是歐洲。

本報告提供全球腎臟用醫療設備及服務市場調查,市場概要,各產品、應用領域、地區的市場規模的變化與預測,市場趨勢,成長要素、阻礙因素以及市場機會、課題分析,競爭情形,主要企業的簡介等,全面性資訊。

目錄

第1章 簡介

  • 市場定義

第2章 調查方法

第3章 摘要整理

第4章 主要影響要素

第5章 市場概要

  • 目前市場方案
  • 波特的五力分析
    • 買方議價能力
    • 供給企業談判力
    • 新加入業者的威脅
    • 替代品的威脅
    • 競爭企業間的敵對關係

第6章 成長要素,阻礙因素,機會,課題分析

  • 市場成長要素
    • 腎臟疾病的發生率上升
    • 糖尿病及高血壓的罹患率上升
    • 老年人口的增加
    • 對先進醫療的需求增加
    • 認知度及取得性提高
  • 市場阻礙因素
    • 償付相關問題
    • 開發中地區的認知度的缺乏
  • 市場機會
  • 主要課題

第7章 市場區隔

  • 各產品
    • 透析用醫療設備
    • 腎除神經導管術用醫療設備
    • 安裝型人工腎臟
    • 防止遠位栓塞用醫療設備
  • 各應用領域
    • 腎功能衰竭
    • 慢性腎臟病
    • 末期腎臟疾病
    • 腎臟結石
    • 高血壓
    • 糖尿病
    • 貧血
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲
    • 南美

第8章 競爭情形

  • 合併及收購分析
  • 協定,合作,夥伴關係
  • 新產品的銷售

第9章 主要企業

  • B. Braun Melsungen AG
  • Baxter International, Inc.
  • Boston Scientific Corporation
  • Covidien
  • DaVita Healthcare Partners, Inc.
  • Fresenius Medical
  • Infomed SA
  • Medtronic
  • Nipro
  • St. Jude Medical, Inc
  • 清單並未完全網羅

第10章 市場未來展望

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 47965

The global renal medical devices and services market is expected to register a CAGR of about 6% during 2018-2023 (the forecast period). North America, followed by Europe, accounted for the largest share of the market for renal medical devices and services.

Increasing Incidences of Kidney Diseases

Across the globe, chronic kidney disease (CKD) is a major concern, which incurs high economic costs to health systems. It is also an independent risk factor for cardiovascular disease (CVD). All stages of CKD are associated with the increased risks of cardiovascular morbidity, premature mortality, and/or decreased quality of life. CKD is usually asymptomatic until its later stages, where there is a lack in accurate prevalence data. According to independent research estimates, CKD has a high global prevalence ranging between 11-13% with the majority comprising of stage three incidences. Consequently, there is a huge demand for renal medical devices and services, which, in turn, is driving its market growth. Additionally, factors, like increasing prevalence of diabetes and growing aging population worldwide, is responsible for driving the market growth.

Reimbursement Issues

The current HCFA approach, to stipulate the services which are to be included within the composite rate, is largely empirical and involves several steps. First, the Medicare Provider Reimbursement Manual (HCFA, 1989) lists that the general services that are to be included in the composite rate, in terms of those historically determined by providers, as necessary. HCFA modifies the list over time as clinical knowledge and practices change. This list does not specify a quality standard regarding the services to be delivered but relies on providers to set an implicit standard, with the specific mix of services to be determined by each provider. Although Medicare regulations establish some structural standards for care, and state health code requirements set additional standards (mostly structural), none of these efforts attempts to describe what an adequate set of dialysis services includes. Consequently, the aberrations arising from the same hinder the market growth. Similarly, factors, like lack of awareness regarding renal complications and associated interventions in developing nations, are impeding the growth of renal medical devices and services market.

North America to Dominate the Market Growth

As of 2017, North America accounted for the largest market share, of approximately 40%, of the global market. In North America, due to the availability of robust healthcare infrastructure, the demand for renal medical devices and services is increasing. The rising incidences of renal and cardiovascular complications are also contributing to this demand growth. North America has one of the highest obese patient pools, therefore renal complication incidences is increasing in the region. The region is a home to two of the largest vendors of renal medical devices. This factor is likely to boost the adoption rate of these devices in local geographies and, consequently help North America to occupy the largest market share in the global renal medical devices and services market.

Key Developments in the Market

January 2018 - DaVita Inc., a leading provider of kidney care services in the United States, partnered with Epic, the most widely used electronic health record (EHR), which will enhance and grow technological capabilities within DaVita Physician Solutions' chronic kidney disease (CKD) EHR platform.

December 2017 - Fresenius Medical Care, the world's largest provider of dialysis products and services, closed the divestment of Shiel Medical Laboratory to Quest Diagnostics. This divestment follows the expiration of the comment period under the Hart-Scott-Rodino Antitrust Improvements Act.

Major Players: B. BRAUN MELSUNGEN AG, BAXTER INTERNATIONAL, INC., BOSTON SCIENTIFIC CORPORATION, COVIDIEN, DAVITA HEALTHCARE PARTNERS, INC., FRESENIUS MEDICAL, INFOMED SA, MEDTRONIC, NIPRO CORPORATION, AND ST. JUDE MEDICAL, INC., among others.

Reasons to Purchase the Report

Current and future renal medical devices and services market outlook in the developed and emerging markets

Various perspectives of the market with the help of Porter's five forces analysis

The segment that is expected to dominate the market

Regions that are expected to witness the fastest growth rates during the forecast period

The latest developments, market shares, and strategies that are employed by the major market players

3 months analyst support, along with the Market Estimate sheet (in Excel)

Customization of the Report

This report can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

Table of Contents

1. Introduction

  • 1.1 Market Definition

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview

  • 5.1 Current Market Scenario
  • 5.2 Porter's Five Forces Analysis
    • 5.2.1 Bargaining Power of Suppliers
    • 5.2.2 Bargaining Power of Consumers
    • 5.2.3 Threat of New Entrants
    • 5.2.4 Threat of Substitute Product and Services
    • 5.2.5 Competitive Rivalry Within the Industry

6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

  • 6.1 Market Drivers
    • 6.1.1 Increasing Incidences of Kidney Diseases
    • 6.1.2 Increase Prevalence of Diabetes and High Blood Pressure Conditions
    • 6.1.3 Growing Aging Population
    • 6.1.4 Rising Demand for Advanced Therapies
    • 6.1.5 Increasing Awareness and Affordability
  • 6.2 Market Restraints
    • 6.2.1 Reimbursement Issues
    • 6.2.2 Lack of Awareness in Developing Regions
  • 6.3 Opportunities
  • 6.4 Key Challenges

7. Market Segmentation

  • 7.1 By Product
    • 7.1.1 Dialysis Equipment
      • 7.1.1.1 Peritoneal Dialysis Equipment
      • 7.1.1.2 Hemodialysis Equipment
      • 7.1.1.3 Hemofiltration Equipment
      • 7.1.1.4 Hemodiafiltration Equipment
      • 7.1.1.5 Intestinal Dialysis Equipment
      • 7.1.1.6 CRRT
    • 7.1.2 Renal Denervation Devices
      • 7.1.2.1 Ultrasound-based Renal Denervation Systems
      • 7.1.2.2 Renal Sympathetic Denervation Devices
      • 7.1.2.3 Radiofrequency-based Renal Denervation Systems
      • 7.1.2.4 Micro-infusion Catheter-based Renal Denervation Systems
    • 7.1.3 Wearable Artificial Kidney Device
    • 7.1.4 Distal Embolic Protection Devices
      • 7.1.4.1 Filter Baskets
      • 7.1.4.2 Distal Occlusion Balloons
      • 7.1.4.3 Proximal Occlusion Balloons
  • 7.2 By Application
    • 7.2.1 Kidney Failure
    • 7.2.2 Chronic Kidney Disease
    • 7.2.3 End-stage Kidney Disease
    • 7.2.4 Renal Kidney Stone Disease
    • 7.2.5 Hypertension
    • 7.2.6 Diabetes
    • 7.2.7 Anemia
  • 7.3 By Geography
    • 7.3.1 North America
      • 7.3.1.1 United States
      • 7.3.1.2 Canada
      • 7.3.1.3 Mexico
    • 7.3.2 Europe
      • 7.3.2.1 France
      • 7.3.2.2 United Kingdom
      • 7.3.2.3 Germany
      • 7.3.2.4 Italy
      • 7.3.2.5 Spain
      • 7.3.2.6 Rest of Europe
    • 7.3.3 Asia-Pacific
      • 7.3.3.1 India
      • 7.3.3.2 China
      • 7.3.3.3 Japan
      • 7.3.3.4 Australia
      • 7.3.3.5 South Korea
      • 7.3.3.6 Rest of Asia-Pacific
    • 7.3.4 Middle East & Africa
      • 7.3.4.1 GCC
      • 7.3.4.2 South Africa
      • 7.3.4.3 Rest of Middle East & Africa
    • 7.3.5 South America
      • 7.3.5.1 Brazil
      • 7.3.5.2 Argentina
      • 7.3.5.3 Rest of South America

8. Competitive Landscape

  • 8.1 Mergers and Acquisition Analysis
  • 8.2 Agreements, Collaborations, and Partnerships
  • 8.3 New Products Launches

9. Key Players

  • 9.1 B. Braun Melsungen AG
  • 9.2 Baxter International, Inc.
  • 9.3 Boston Scientific Corporation
  • 9.4 Covidien
  • 9.5 DaVita Healthcare Partners, Inc.
  • 9.6 Fresenius Medical
  • 9.7 Infomed SA
  • 9.8 Medtronic
  • 9.9 Nipro Corporation
  • 9.10 St. Jude Medical, Inc
  • 9.11 List Not Exhaustive

10. Future of the Market

Back to Top